{"id":185272,"name":"AMERICAN SOCIETY FOR HISTOCOMPATIBILITY & IMMUNOGENETICS","slug":"american-society-for-histocompatibility-immunogenetics","state":"NJ","country":"United States of America","description":"association to advance the science and application of histocompatibility & immunogenetics","totalSpending":240000,"filings":14,"yearlySpending":[{"year":2018,"income":10000},{"year":2019,"income":80000},{"year":2020,"income":80000},{"year":2021,"income":70000}],"issues":["MMM","HCR","BUD"],"firms":["POLSINELLI PC"],"lobbyists":["TIMOTHY CASEY","JAMES FLEISCHMANN","JULIE SHROYER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Food & Drug Administration (FDA)","Centers For Medicare and Medicaid Services (CMS)","Labor, Dept of (DOL)","Centers For Disease Control & Prevention (CDC)"],"sampleDescriptions":["Issues relating to Medicare reimbursement for clinical laboratory services; Appropriate regulatory and oversight framework","Issues relating to Medicare reimbursement for clinical laboratory services; Appropriate regulatory and oversight framework\n\nLegislation relating to regulation of in vitro clinical tests and laboratory","CMS and FDA jurisdiction for the following:\n\nOrgan Procurement Optimization Act \nVALID Act, Verifying Accurate, Leading-edge IVCT Development Act\nIssues impacting lab regulations and reimbursement","S. 2063, Organ Procurement Optimization Act \nVALID Act, Verifying Accurate, Leading-edge IVCT Development Act\nAgencies lobbied: House, Senate","Issues related to transplant Patients and Anti-Rejection Drugs\nIssues impacting lab regulations and reimbursement\nAgencies lobbied: House, Senate"],"years":[2018,2019,2020,2021]}